Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,535.05
(
-1.08%
)
US TECH 100
23,376.40
(
-1.45%
)
Dow Jones
45,752.72
(
-0.58%
)
Brent Oil
107.30
(
2.74%
)
Bitcoin
69,636.00
(
-0.38%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: turtlepower post# 139052

Friday, 03/23/2012 9:52:26 AM

Friday, March 23, 2012 9:52:26 AM

Post# of 257262
>>Will this be an issue especially with the cancer issue they had earlier.

No. Neurontin dosing is often higher and the preclinical cancer issue was a complete red herring.

At this point I don't see the PHN approval as being much of a driver without the GSK situation being sorted out.

Peter
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today